Bharat Parenterals Stock

Bharat Parenterals Liabilities 2024

Bharat Parenterals Liabilities

3.07 B INR

Ticker

541096.BO

ISIN

INE365Y01019

In 2024, Bharat Parenterals's total liabilities amounted to 3.07 B INR, a 408.96% difference from the 602.31 M INR total liabilities in the previous year.

Bharat Parenterals Aktienanalyse

What does Bharat Parenterals do?

Bharat Parenterals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Bharat Parenterals's Liabilities

Bharat Parenterals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Bharat Parenterals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Bharat Parenterals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Bharat Parenterals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Bharat Parenterals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Bharat Parenterals stock

What is the level of liabilities of Bharat Parenterals this year?

Bharat Parenterals has a debt balance of 3.07 B INR this year.

What were the liabilities of Bharat Parenterals compared to the previous year?

The liabilities of Bharat Parenterals have increased by 408.96% increased compared to the previous year.

What are the consequences of high debt for investors of Bharat Parenterals?

High liabilities can pose a risk for investors of Bharat Parenterals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Bharat Parenterals?

Low liabilities mean that Bharat Parenterals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Bharat Parenterals affect the company?

An increase in liabilities of Bharat Parenterals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Bharat Parenterals affect the company?

A decrease in the liabilities of Bharat Parenterals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Bharat Parenterals?

Some factors that can influence the liabilities of Bharat Parenterals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Bharat Parenterals so important for investors?

The liabilities of Bharat Parenterals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Bharat Parenterals take to modify the liabilities?

To change its liabilities, Bharat Parenterals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Bharat Parenterals pay?

Over the past 12 months, Bharat Parenterals paid a dividend of 1 INR . This corresponds to a dividend yield of about 0.06 %. For the coming 12 months, Bharat Parenterals is expected to pay a dividend of 1 INR.

What is the dividend yield of Bharat Parenterals?

The current dividend yield of Bharat Parenterals is 0.06 %.

When does Bharat Parenterals pay dividends?

Bharat Parenterals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bharat Parenterals?

Bharat Parenterals paid dividends every year for the past 2 years.

What is the dividend of Bharat Parenterals?

For the upcoming 12 months, dividends amounting to 1 INR are expected. This corresponds to a dividend yield of 0.06 %.

In which sector is Bharat Parenterals located?

Bharat Parenterals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bharat Parenterals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bharat Parenterals from 8/1/2024 amounting to 1 INR, you needed to have the stock in your portfolio before the ex-date on 6/25/2024.

When did Bharat Parenterals pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Bharat Parenterals in the year 2023?

In the year 2023, Bharat Parenterals distributed 0.75 INR as dividends.

In which currency does Bharat Parenterals pay out the dividend?

The dividends of Bharat Parenterals are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bharat Parenterals

Our stock analysis for Bharat Parenterals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bharat Parenterals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.